MARGUERITE WATERS: Open Payments
NPI 1356010755 · AUBURN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,261 in 100 payments from 11 companies in 2025. Trend: 2023 $893 · 2024 $1,947 · 2025 $2,261
Food & beverage: $2,182Education: $79
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $483 |
| Ardelyx, Inc. | 18 | $444 |
| ABBVIE INC. | 30 | $386 |
| GENZYME CORPORATION | 12 | $327 |
| Lilly USA, LLC | 9 | $183 |
| Janssen Scientific Affairs, LLC | 1 | $126 |
| Regeneron Healthcare Solutions, Inc. | 3 | $89 |
| Phathom Pharmaceuticals, Inc. | 6 | $88 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
Products named: TREMFYA, IBSRELA, DUPIXENT, OMVOH, SKYRIZI, RINVOQ, VOQUEZNA, LINZESS.
Industry payments across AL — which companies pay providers there.
